Hmmmm, now I wish some would become upset with me in some of my posts and then offer biopharm a job half as good as Rahul : )
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!